Skip to main content

$0.038 0.005 (15.15%)

High

$0.04

Low

$0.03

Trades

55

Turnover

$121,565

Volume

3,767,585
30 June 2023 at 4:10pm
Register to track RSH and receive email alerts.
Subject
RSH Ann: Update - Proposed issue of securities - RSH

RSH Ann: Reinstatement to Quotation

RSH Ann: Copy of investor presentation

RSH Ann: Proposed issue of securities - RSH

RSH Ann: Completion of Placement

RSH Ann: Quarterly Activities/Appendix 4C Cash Flow Report

RSH Ann: Voluntary Suspension

RSH Ann: Trading Halt

RSH Ann: Final Director's Interest Notice - TD

RSH Ann: Director Resignation - TD

RSH Ann: EAS Advisors LLC appointed to assist with US growth

RSH Ann: Broker Briefing - full presentation

RSH Ann: Tech/Biotech Webinar - presentation

RSH Ann: CEO to present at Tech/Biotech Investor Webinar

RSH Ann: RPM pilot program at Children's Hospital of Michigan

RSH Ann: Notification regarding unquoted securities - RSH

RSH Ann: Half Yearly Report and Accounts

RSH Ann: Investor webinar and Q&A to be held Feb 23rd

RSH Ann: Second RPM Agreement with Access TeleHealth

RSH Ann: Respiri secures a second order from mTeleHealth

RSH Ann: Proposed issue of securities - RSH

RSH Ann: Quarterly Activities/Appendix 4C Cash Flow Report

RSH Ann: Respiri enters Distribution/Marketing Agreement in USA

RSH Ann: Respiri to present today at MST Financial Forum

RSH Ann: Respiri to present at NWR Virtual Healthcare Day

RSH Ann: Results of AGM

RSH Ann: AGM - Chairman's Address and CEO presentation

RSH Ann: Quarterly Activities/Appendix 4C Cash Flow Report

RSH Ann: Notice of General Meeting

RSH Ann: Annual Report - Corporate Governance Statement

RSH Ann: Annual Report - App 4G

RSH Ann: Preliminary Final Report

RSH Ann: NWR Conference Presentation - amended

RSH Ann: NWR Conference Presentation

RSH Ann: Quarterly Activities/Appendix 4C Cash Flow Report

RSH Ann: Respiri to present at NWR Virtual Investor Conference

RSH Ann: Top 20 shareholders and Distribution Schedule

RSH Ann: T/O Bid lapsed and Ceasing to be sub. shareholder for ADR

RSH Ann: Defeating Conditions Notice

RSH Ann: Clarification Announcement

RSH Ann: Response to ASX Query

RSH Ann: ADR: Despatch of Target's Statement

RSH Ann: ADR: Target's Statement

RSH Ann: Webinar presentation - Investor Update

RSH Ann: Pharmacy Network to Commence Sales of wheezo

RSH Ann: Change of Director's Interest Notice - MM

RSH Ann: Investor webinar & Q&A

RSH Ann: ADR: Letter to Shareholders re takeover offer

RSH Ann: Notice of Dispatch

RSH Ann: Trading Update

Register to track RSH and receive email alerts.

Similar Companies

AT1
COH
CSX
CYC
EMV
IBX
IPD
MX1
SOM